![Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy - ScienceDirect Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1567576918302315-gr2.jpg)
Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy - ScienceDirect
![Low dose Naltrexone for induction of remission in inflammatory bowel disease patients. - Abstract - Europe PMC Low dose Naltrexone for induction of remission in inflammatory bowel disease patients. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5845217/bin/12967_2018_1427_Fig4_HTML.jpg)
Low dose Naltrexone for induction of remission in inflammatory bowel disease patients. - Abstract - Europe PMC
![Low dose Naltrexone for induction of remission in inflammatory bowel disease patients | Journal of Translational Medicine | Full Text Low dose Naltrexone for induction of remission in inflammatory bowel disease patients | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-018-1427-5/MediaObjects/12967_2018_1427_Fig3_HTML.gif)
Low dose Naltrexone for induction of remission in inflammatory bowel disease patients | Journal of Translational Medicine | Full Text
![Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy - ScienceDirect Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1567576918302315-gr1.jpg)